{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:19:13Z","timestamp":1770524353359,"version":"3.49.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":109,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Der Begriff der diabetischen Neuropathie ist eine Sammelbezeichnung f\u00fcr Erkrankungen des peripheren Nervensystems die als Sp\u00e4tkomplikation des Diabetes mellitus auftreten.<\/jats:p><jats:p>Die Leitlinienempfehlungen beschreiben die klinischen Symptome und diagnostischen M\u00f6glichkeiten, sowie die Therapiema\u00dfnahmen insbesondere bei der schmerzhaften Form der sensomotorischen Neuropathie, einschlie\u00dflich der komplexen Problematik des diabetischen Fu\u00dfes.<\/jats:p>","DOI":"10.1007\/s00508-023-02167-7","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T23:03:25Z","timestamp":1682550205000},"page":"164-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diabetische Neuropathie und diabetischer Fu\u00df (Update\u00a02023)","Diabetic neuropathy and diabetic foot syndrome (update\u00a02023)"],"prefix":"10.1007","volume":"135","author":[{"given":"Gerd","family":"K\u00f6hler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies","family":"Eichner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidemarie","family":"Abrahamian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Kofler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"issue":"Suppl 1","key":"2167_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2337\/dc18-S010","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. 10. Microvascular complications and foot care: Standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):105\u201318.","journal-title":"Diabetes Care"},{"issue":"1","key":"2167_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman\u00a0EL, Callaghan\u00a0BC, Pop-Busui\u00a0R, Zochodne\u00a0DW, Wright\u00a0DE, Bennett\u00a0DL, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):41.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"2167_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","volume":"11","author":"BC Callaghan","year":"2012","unstructured":"Callaghan\u00a0BC, Cheng\u00a0HT, Stables\u00a0CL, Smith\u00a0AL, Feldman\u00a0EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521\u201334.","journal-title":"Lancet Neurol"},{"issue":"2","key":"2167_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/BF00400697","volume":"36","author":"MJ Young","year":"1993","unstructured":"Young\u00a0MJ, Boulton\u00a0AJ, MacLeod\u00a0AF, Williams\u00a0DR, Sonksen\u00a0PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150\u20134.","journal-title":"Diabetologia"},{"issue":"2","key":"2167_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1526-4637.2008.00555.x","volume":"10","author":"D Ziegler","year":"2009","unstructured":"Ziegler\u00a0D, Rathmann\u00a0W, Dickhaus\u00a0T, Meisinger\u00a0C, Mielck\u00a0A, KORA Study Group. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA\/KORA Augsburg Surveys S2 and S3. Pain Med. 2009;10(2):393\u2013400.","journal-title":"Pain Med"},{"issue":"11","key":"2167_CR6","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2337\/diab.38.11.1456","volume":"38","author":"RE Maser","year":"1989","unstructured":"Maser\u00a0RE, Steenkiste\u00a0AR, Dorman\u00a0JS, Nielsen\u00a0VK, Bass\u00a0EB, Manjoo\u00a0Q, et\u00a0al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes. 1989;38(11):1456\u201361.","journal-title":"Diabetes"},{"issue":"6","key":"2167_CR7","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1212\/WNL.42.6.1164","volume":"42","author":"PJ Dyck","year":"1992","unstructured":"Dyck\u00a0PJ, Karnes\u00a0JL, O\u2019Brien\u00a0PC, Litchy\u00a0WJ, Low\u00a0PA, Melton\u00a0LJ. The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity. Neurology. 1992;42(6):1164\u201370.","journal-title":"Neurology"},{"issue":"4","key":"2167_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1212\/WNL.43.4.817","volume":"43","author":"PJ Dyck","year":"1993","unstructured":"Dyck\u00a0PJ, Kratz\u00a0KM, Karnes\u00a0JL, Litchy\u00a0WJ, Klein\u00a0R, Pach\u00a0JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a\u00a0population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817\u201324.","journal-title":"Neurology"},{"issue":"9","key":"2167_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1046\/j.1464-5491.2002.00778.x","volume":"19","author":"LV van de Poll-Franse","year":"2002","unstructured":"van de Poll-Franse\u00a0LV, Valk\u00a0GD, Renders\u00a0CM, Heine\u00a0RJ, van Eijk\u00a0JTM. Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors. Diabet Med. 2002;19(9):771\u20136.","journal-title":"Diabet Med"},{"issue":"Suppl 1","key":"2167_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/dmrr.2239","volume":"28","author":"S Tesfaye","year":"2012","unstructured":"Tesfaye\u00a0S, Selvarajah\u00a0D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28(Suppl 1):8\u201314.","journal-title":"Diabetes Metab Res Rev"},{"issue":"7","key":"2167_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s001250051227","volume":"42","author":"AA Sima","year":"1999","unstructured":"Sima\u00a0AA, Sugimoto\u00a0K. Experimental diabetic neuropathy: an update. Diabetologia. 1999;42(7):773\u201388.","journal-title":"Diabetologia"},{"issue":"10","key":"2167_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrneurol.2011.137","volume":"7","author":"AM Vincent","year":"2011","unstructured":"Vincent\u00a0AM, Callaghan\u00a0BC, Smith\u00a0AL, Feldman\u00a0EL. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol. 2011;7(10):573\u201383.","journal-title":"Nat Rev Neurol"},{"issue":"Pt 12","key":"2167_CR13","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1093\/brain\/124.12.2448","volume":"124","author":"S Yagihashi","year":"2001","unstructured":"Yagihashi\u00a0S, Yamagishi\u00a0SI, Wada\u00a0RR, Baba\u00a0M, Hohman\u00a0TC, Yabe-Nishimura\u00a0C, et al. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain. 2001;124(Pt 12):2448\u201358.","journal-title":"Brain"},{"issue":"1","key":"2167_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10286-010-0084-4","volume":"21","author":"RD Hoeldtke","year":"2011","unstructured":"Hoeldtke\u00a0RD, Bryner\u00a0KD, VanDyke\u00a0K. Oxidative stress and autonomic nerve function in early type 1 diabetes. Clin Auton Res. 2011;21(1):19\u201328.","journal-title":"Clin Auton Res"},{"issue":"8","key":"2167_CR15","first-page":"e1577","volume":"9","author":"A Khan","year":"2017","unstructured":"Khan\u00a0A, Shafiq\u00a0I, Hassan Shah\u00a0M. Prevalence of vitamin B12 deficiency in patients with type II diabetes mellitus on metformin: A study from Khyber Pakhtunkhwa. Cureus. 2017;9(8):e1577.","journal-title":"Cureus"},{"issue":"10","key":"2167_CR16","doi-asserted-by":"publisher","first-page":"e0204420","DOI":"10.1371\/journal.pone.0204420","volume":"13","author":"TJ Alharbi","year":"2018","unstructured":"Alharbi\u00a0TJ, Tourkmani\u00a0AM, Abdelhay\u00a0O, Alkhashan\u00a0HI, Al-Asmari\u00a0AK, Bin Rsheed\u00a0AM, et al. The association of metformin use with vitamin B12 deficiency and peripheral neuropathy in Saudi individuals with type 2 diabetes mellitus. PLoS ONE. 2018;13(10):e204420.","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"2167_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00508-019-1471-z","volume":"131","author":"M Clodi","year":"2019","unstructured":"Clodi\u00a0M, Abrahamian\u00a0H, Brath\u00a0H, Brix\u00a0J, Drexel\u00a0H, Fasching\u00a0P, et\u00a0al. Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019). Wien Klin Wochenschr. 2019;131(Suppl 1):27\u201338.","journal-title":"Wien Klin Wochenschr"},{"issue":"3","key":"2167_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s11892-001-0037-3","volume":"1","author":"D Ziegler","year":"2001","unstructured":"Ziegler\u00a0D. Diagnosis and treatment of diabetic autonomic neuropathy. Curr Diab Rep. 2001;1(3):216\u201327.","journal-title":"Curr Diab Rep"},{"issue":"5","key":"2167_CR19","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","volume":"26","author":"AI Vinik","year":"2003","unstructured":"Vinik\u00a0AI, Maser\u00a0RE, Mitchell\u00a0BD, Freeman\u00a0R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5):1553\u201379.","journal-title":"Diabetes Care"},{"issue":"7","key":"2167_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/dmrr.1225","volume":"27","author":"S Tesfaye","year":"2011","unstructured":"Tesfaye\u00a0S, Vileikyte\u00a0L, Rayman\u00a0G, Sindrup\u00a0SH, Perkins\u00a0BA, Baconja\u00a0M, et\u00a0al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011;27(7):629\u201338.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"2167_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/ptj\/76.1.68","volume":"76","author":"MJ Mueller","year":"1996","unstructured":"Mueller\u00a0MJ. Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments. Phys Ther. 1996;76(1):68\u201371.","journal-title":"Phys Ther"},{"issue":"3","key":"2167_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2337\/diacare.26.3.697","volume":"26","author":"JWG Meijer","year":"2003","unstructured":"Meijer\u00a0JWG, Bosma\u00a0E, Lefrandt\u00a0JD, Links\u00a0TP, Smit\u00a0AJ, Stewart\u00a0RE, et\u00a0al. Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. Diabetes Care. 2003;26(3):697\u2013701.","journal-title":"Diabetes Care"},{"issue":"5","key":"2167_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1046\/j.1464-5491.2003.00931.x","volume":"20","author":"M Rahman","year":"2003","unstructured":"Rahman\u00a0M, Griffin\u00a0SJ, Rathmann\u00a0W, Wareham\u00a0NJ. How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures. Diabet Med. 2003;20(5):368\u201374.","journal-title":"Diabet Med"},{"issue":"6","key":"2167_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/00004691-199711000-00011","volume":"14","author":"CF Bolton","year":"1997","unstructured":"Bolton\u00a0CF, Remtulla\u00a0H, Toth\u00a0B, Bernardi\u00a0L, Lindsay\u00a0RM, Maryniak\u00a0O, et\u00a0al. Distinctive electrophysiological features of denervated muscle in uremic patients. J\u00a0Clin Neurophysiol. 1997;14(6):539\u201342.","journal-title":"J Clin Neurophysiol"},{"issue":"4","key":"2167_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.clinph.2019.01.002","volume":"130","author":"M Kofler","year":"2019","unstructured":"Kofler\u00a0M, Leis\u00a0AA, Valls-Sol\u00e9\u00a0J. Cutaneous silent periods\u2014Part 1: Update on physiological mechanisms. Clin Neurophysiol. 2019;130(4):588\u2013603.","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"2167_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/WNP.0000000000000681","volume":"37","author":"J Casanova-Molla","year":"2020","unstructured":"Casanova-Molla\u00a0J, Valls-Sol\u00e9\u00a0J. Electrodiagnostic testing of small fiber neuropathies: A review of existing guidelines. J\u00a0Clin Neurophysiol. 2020;37(4):288\u201393.","journal-title":"J Clin Neurophysiol"},{"issue":"7","key":"2167_CR27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1468-1331.2010.03023.x","volume":"17","author":"G Lauria","year":"2010","unstructured":"Lauria\u00a0G, Hsieh\u00a0ST, Johansson\u00a0O, Kennedy\u00a0WR, Leger\u00a0JM, Mellgren\u00a0SI, et\u00a0al. European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a\u00a0joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2010;17(7):903\u2013e49.","journal-title":"Eur J Neurol"},{"issue":"5","key":"2167_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00125-003-1086-8","volume":"46","author":"RA Malik","year":"2003","unstructured":"Malik\u00a0RA, Kallinikos\u00a0P, Abbott\u00a0CA, van Schie\u00a0CHM, Morgan\u00a0P, Efron\u00a0N, et al. Corneal confocal microscopy: a\u00a0non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia. 2003;46(5):683\u20138.","journal-title":"Diabetologia"},{"issue":"S 01","key":"2167_CR29","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1055\/a-1284-6524","volume":"129","author":"B Kulzer","year":"2021","unstructured":"Kulzer\u00a0B, Albus\u00a0C, Herpertz\u00a0S, Kruse\u00a0J, Lange\u00a0K, Lederbogen\u00a0F, et\u00a0al. Psychosocial factors and diabetes. Exp Clin Endocrinol Diabetes. 2021;129(S 01):S91\u2013105.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"2167_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s00508-019-1458-9","volume":"131","author":"H Abrahamian","year":"2019","unstructured":"Abrahamian\u00a0H, Kautzky-Willer\u00a0A, Rie\u00dfland-Seifert\u00a0A, Fasching\u00a0P, Ebenbichler\u00a0C, Kautzky\u00a0A, et al. Psychische Erkrankungen und Diabetes mellitus (Update 2019). Wien Klin Wochenschr. 2019;131(1):186\u201395.","journal-title":"Wien Klin Wochenschr"},{"issue":"S 1","key":"2167_CR31","first-page":"S206","volume":"15","author":"S Morbach","year":"2020","unstructured":"Morbach\u00a0S, Lobmann\u00a0R, Eckhard\u00a0M, M\u00fcller\u00a0E, Reike\u00a0H, Risse\u00a0A, et\u00a0al. Diabetisches Fu\u00dfsyndrom. Diabetol Stoffwechsel. 2020;15(S 1):S206\u201315.","journal-title":"Diabetol Stoffwechsel"},{"key":"2167_CR32","doi-asserted-by":"publisher","first-page":"534372","DOI":"10.3389\/fpubh.2020.534372","volume":"8","author":"Y Lu","year":"2020","unstructured":"Lu\u00a0Y, Xing\u00a0P, Cai\u00a0X, Luo\u00a0D, Li\u00a0R, Lloyd\u00a0C, et al. Prevalence and risk factors for diabetic peripheral neuropathy in type 2 diabetic patients from 14 countries: Estimates of the INTERPRET-DD study. Front Public Health. 2020;8:534372.","journal-title":"Front Public Health"},{"issue":"1","key":"2167_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1900\/RDS.2021.17.17","volume":"17","author":"PRJ Vas","year":"2021","unstructured":"Vas\u00a0PRJ, Papanas\u00a0N. Diabetic peripheral neuropathy and depression: dancing with wolves?\u2014Mini-review and commentary on Alghafri et\u00a0al. \u201cScreening for depressive symptoms amongst patients with diabetic peripheral neuropathy\u201d. Rev Diabet Stud. 2021;17(1):17\u201320.","journal-title":"Rev Diabet Stud"},{"issue":"1","key":"2167_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/1753-0407.12822","volume":"11","author":"R Elgendy","year":"2019","unstructured":"Elgendy\u00a0R, Desch\u00eanes\u00a0SS, Burns\u00a0RJ, Levy\u00a0M, Schmitz\u00a0N. Alcohol consumption, depressive symptoms, and the incidence of diabetes-related complications. J\u00a0Diabetes. 2019;11(1):14\u201322.","journal-title":"J Diabetes"},{"issue":"Supplement_1","key":"2167_CR35","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.2337\/dc22-S012","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2021","unstructured":"American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: Standards of medical care in diabetes\u20142022. Diabetes Care. 2021;45(Supplement_1):S185\u2013S94.","journal-title":"Diabetes Care"},{"key":"2167_CR36","unstructured":"Gillhausen K, Freynhagen R, Maih\u00f6fner C. DIAGNOSE UND THERAPIE NEUROPATHISCHER SCHMERZEN:EINE PRAKTISCHE HILFE F\u00dcR DEN HAUS\u00c4RZTLICHEN ALLTAG. https:\/\/docplayer.org\/123308213-Diagnose-und-therapie-neuropathischer-schmerzen.html. Zugegriffen: 30. Okt. 2022."},{"key":"2167_CR37","doi-asserted-by":"crossref","unstructured":"Schlereth T. Diagnose und nicht interventionelle Therapie neuropathischer Schmerzen, S2k-Leitlinie, 2019. Deutsche Gesellschaft f\u00fcr Neurologie. https:\/\/dgn.org\/leitlinien. Zugegriffen: 30. Okt. 2022, (Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie).","DOI":"10.1007\/s42451-019-00139-8"},{"key":"2167_CR38","series-title":"Schmerz Nachrichten","volume-title":"CHRONISCHE PERIPHERE NEUROPATHISCHE SCHMERZEN: Diagnose und Therapie in der Praxis","author":"G Graggober","year":"2020","unstructured":"Graggober\u00a0G, et\u00a0al. CHRONISCHE PERIPHERE NEUROPATHISCHE SCHMERZEN: Diagnose und Therapie in der Praxis. Schmerz Nachrichten, Bd. 1d. 2020."},{"issue":"1\u20132","key":"2167_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neurol.2018.08.005","volume":"175","author":"N Attal","year":"2019","unstructured":"Attal\u00a0N. Pharmacological treatments of neuropathic pain: The latest recommendations. Rev Neurol (Paris). 2019;175(1\u20132):46\u201350.","journal-title":"Rev Neurol (Paris)"},{"issue":"10","key":"2167_CR40","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","volume":"49","author":"HN Bockbrader","year":"2010","unstructured":"Bockbrader\u00a0HN, Wesche\u00a0D, Miller\u00a0R, Chapel\u00a0S, Janiczek\u00a0N, Burger\u00a0P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010;49(10):661\u20139.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"2167_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup\u00a0NB, Attal\u00a0N, Haroutounian\u00a0S, McNicol\u00a0E, Baron\u00a0R, Dworkin\u00a0RH, et al. Pharmacotherapy for neuropathic pain in adults: a\u00a0systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162\u201373.","journal-title":"Lancet Neurol"},{"issue":"1","key":"2167_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00325481.2020.1857992","volume":"133","author":"R Freynhagen","year":"2021","unstructured":"Freynhagen\u00a0R, Baron\u00a0R, Kawaguchi\u00a0Y, Malik\u00a0RA, Martire\u00a0DL, Parsons\u00a0B, et\u00a0al. Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration. Postgrad Med. 2021;133(1):1\u20139.","journal-title":"Postgrad Med"},{"issue":"11","key":"2167_CR43","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/AJP.0000000000000339","volume":"32","author":"A Gonz\u00e1lez-Duarte","year":"2016","unstructured":"Gonz\u00e1lez-Duarte\u00a0A, Lem\u00a0M, D\u00edaz-D\u00edaz\u00a0E, Castillo\u00a0C, C\u00e1rdenas-Soto\u00a0K. The efficacy of pregabalin in the treatment of prediabetic neuropathic pain. Clin J Pain. 2016;32(11):927\u201332.","journal-title":"Clin J Pain"},{"key":"2167_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub4\/full","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen\u00a0PJ, Derry\u00a0S, Bell\u00a0RF, Rice\u00a0AS, T\u00f6lle\u00a0TR, Phillips\u00a0T, et\u00a0al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017; https:\/\/doi.org\/10.1002\/14651858.CD007938.pub4\/full.","journal-title":"Cochrane Database Syst Rev"},{"key":"2167_CR45","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/jama.2017.21547","volume":"319","author":"A Moore","year":"2018","unstructured":"Moore\u00a0A, Derry\u00a0S, Wiffen\u00a0P. Gabapentin for chronic neuropathic pain. JAMA. 2018;319:818.","journal-title":"JAMA"},{"key":"2167_CR46","unstructured":"PharmNet.Bund. PharmNet.Bund \u2013 Arzneimittel-Informationssystem. https:\/\/www.pharmnet-bund.de\/dynamic\/de\/arzneimittel-informationssystem\/index.html. Zugegriffen: 30. Okt. 2022."},{"issue":"Suppl 2","key":"2167_CR47","first-page":"S336","volume":"16","author":"D Ziegler","year":"2021","unstructured":"Ziegler\u00a0D, Keller\u00a0J, Maier\u00a0C, Pannek\u00a0J. Diabetische Neuropathie. Diabetol Stoffwechs. 2021;16(Suppl 2):S336\u2013S50.","journal-title":"Diabetol Stoffwechs"},{"issue":"4","key":"2167_CR48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF01212087","volume":"5","author":"JA Rull","year":"1969","unstructured":"Rull\u00a0JA, Quibrera\u00a0R, Gonz\u00e1lez-Mill\u00e1n\u00a0H, Lozano Casta\u00f1eda\u00a0O. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia. 1969;5(4):215\u20138.","journal-title":"Diabetologia"},{"issue":"3","key":"2167_CR49","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00108-020-00739-7","volume":"61","author":"J Sachau","year":"2020","unstructured":"Sachau\u00a0J, Fabig\u00a0SC, Rehm\u00a0S, Baron\u00a0R. Therapie der Polyneuropathie\u2014autonome Symptome und Schmerzen. Internist. 2020;61(3):270\u20136.","journal-title":"Internist"},{"key":"2167_CR50","first-page":"CD006044","volume":"12","author":"PJ Wiffen","year":"2013","unstructured":"Wiffen\u00a0PJ, Derry\u00a0S, Moore\u00a0RA. Lamotrigine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2013;12:CD6044.","journal-title":"Cochrane Database Syst Rev"},{"key":"2167_CR51","unstructured":"Redaktion Deutsches \u00c4rzteblatt D\u00c4G. Pharmakotherapie chronischer neuropathischer Schmerzen. Deutsches \u00c4rzteblatt. 2016. https:\/\/www.aerzteblatt.de\/archiv\/181963\/Pharmakotherapie-chronischer-neuropathischer-Schmerzen. Zugegriffen: 30. Okt. 2022."},{"key":"2167_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-57487-4","volume-title":"Praktische Schmerzmedizin","author":"R Baron","year":"2019","unstructured":"Baron\u00a0R, Koppert\u00a0W, Strumpf\u00a0M, Willweber-Strumpf\u00a0A. Interdisziplin\u00e4re Diagnostik \u2013 multimodaleTherapie. In: Praktische Schmerzmedizin. 4.\u00a0Aufl. Berlin, Heidelberg: Springer; 2019.","edition":"4"},{"key":"2167_CR53","first-page":"CD008242","volume":"7","author":"RA Moore","year":"2015","unstructured":"Moore\u00a0RA, Derry\u00a0S, Aldington\u00a0D, Cole\u00a0P, Wiffen\u00a0PJ. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015;7:CD8242.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"2167_CR54","doi-asserted-by":"publisher","first-page":"639","DOI":"10.7326\/M14-0511","volume":"161","author":"ML Griebeler","year":"2014","unstructured":"Griebeler\u00a0ML, Morey-Vargas\u00a0OL, Brito\u00a0JP, Tsapas\u00a0A, Wang\u00a0Z, Carranza Leon\u00a0BG, et al. Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis. Ann Intern Med. 2014;161(9):639\u201349.","journal-title":"Ann Intern Med"},{"issue":"1\u20132","key":"2167_CR55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","volume":"116","author":"DJ Goldstein","year":"2005","unstructured":"Goldstein\u00a0DJ, Lu\u00a0Y, Detke\u00a0MJ, Lee\u00a0TC, Iyengar\u00a0S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005;116(1\u20132):109\u201318.","journal-title":"Pain"},{"issue":"Suppl","key":"2167_CR56","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1016\/j.clinthera.2007.12.002","volume":"29","author":"DK Kajdasz","year":"2007","unstructured":"Kajdasz\u00a0DK, Iyengar\u00a0S, Desaiah\u00a0D, Backonja\u00a0MM, Farrar\u00a0JT, Fishbain\u00a0DA, et al. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. Clin Ther. 2007;29(Suppl):2536\u201346.","journal-title":"Clin Ther"},{"key":"2167_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","volume":"8","author":"A Sultan","year":"2008","unstructured":"Sultan\u00a0A, Gaskell\u00a0H, Derry\u00a0S, Moore\u00a0RA. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurol. 2008;8:29.","journal-title":"BMC Neurol"},{"key":"2167_CR58","first-page":"CD007115","volume":"1","author":"MPT Lunn","year":"2014","unstructured":"Lunn\u00a0MPT, Hughes\u00a0RAC, Wiffen\u00a0PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014;1:CD7115.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2167_CR59","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/annonc\/mdr045","volume":"23","author":"JP Durand","year":"2012","unstructured":"Durand\u00a0JP, Deplanque\u00a0G, Montheil\u00a0V, Gornet\u00a0JM, Scotte\u00a0F, Mir\u00a0O, et al. Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a\u00a0randomized, double-blind, placebo-controlled phase III trial. Ann Oncol. 2012;23(1):200\u20135.","journal-title":"Ann Oncol"},{"issue":"1","key":"2167_CR60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00482-014-1463-x","volume":"29","author":"W H\u00e4user","year":"2015","unstructured":"H\u00e4user\u00a0W, Bock\u00a0F, Engeser\u00a0P, Hege-Scheuing\u00a0G, H\u00fcppe\u00a0M, Lindena\u00a0G, et al. Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain. Schmerz. 2015;29(1):109\u201330.","journal-title":"Schmerz"},{"key":"2167_CR61","unstructured":"Gelbe Liste. Gelbe Liste Pharmindex Online. 2022. https:\/\/www.gelbe-liste.de\/. Zugegriffen: 30. Okt. 2022."},{"key":"2167_CR62","first-page":"CD003726","volume":"6","author":"RM Duehmke","year":"2017","unstructured":"Duehmke\u00a0RM, Derry\u00a0S, Wiffen\u00a0PJ, Bell\u00a0RF, Aldington\u00a0D, Moore\u00a0RA. Tramadol for neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6:CD3726.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2167_CR63","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40261-014-0249-3","volume":"35","author":"S Schwartz","year":"2015","unstructured":"Schwartz\u00a0S, Etropolski\u00a0MS, Shapiro\u00a0DY, Rauschkolb\u00a0C, Vinik\u00a0AI, Lange\u00a0B, et\u00a0al. A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy. Clin Drug Investig. 2015;35(2):95\u2013108.","journal-title":"Clin Drug Investig"},{"issue":"9","key":"2167_CR64","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/ejp.1297","volume":"22","author":"W H\u00e4user","year":"2018","unstructured":"H\u00e4user\u00a0W, Finn\u00a0DP, Kalso\u00a0E, Krcevski-Skvarc\u00a0N, Kress\u00a0HG, Morlion\u00a0B, et al. European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management. Eur J Pain. 2018;22(9):1547\u201364.","journal-title":"Eur J Pain"},{"issue":"11","key":"2167_CR65","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1111\/dme.13083","volume":"33","author":"N \u00c7akici","year":"2016","unstructured":"\u00c7akici\u00a0N, Fakkel\u00a0TM, van Neck\u00a0JW, Verhagen\u00a0AP, Coert\u00a0JH. Systematic review of treatments for diabetic peripheral neuropathy. Diabet Med. 2016;33(11):1466\u201376.","journal-title":"Diabet Med"},{"issue":"10","key":"2167_CR66","first-page":"CD010902","volume":"5","author":"RA Moore","year":"2015","unstructured":"Moore\u00a0RA, Chi\u00a0CC, Wiffen\u00a0PJ, Derry\u00a0S, Rice\u00a0ASC. Oral nonsteroidal anti-inflammatory drugs for neuropathic pain. Cochrane Database Syst Rev. 2015;5(10):CD10902.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2167_CR67","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/j.1532-2149.2013.00415.x","volume":"18","author":"CG Maih\u00f6fner","year":"2014","unstructured":"Maih\u00f6fner\u00a0CG, Heskamp\u00a0MLS. Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study. Eur J Pain. 2014;18(5):671\u20139.","journal-title":"Eur J Pain"},{"issue":"1","key":"2167_CR68","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jviscsurg.2019.09.004","volume":"157","author":"M Prudhomme","year":"2020","unstructured":"Prudhomme\u00a0M, Legras\u00a0A, Delorme\u00a0C, Lansaman\u00a0T, Lanteri-Minet\u00a0M, Medioni\u00a0J, et al. Management of neuropathic pain induced by surgery: Review of the literature by a\u00a0group of experts specialized in pain management, anesthesia and surgery. J\u00a0Visc Surg. 2020;157(1):43\u201352.","journal-title":"J Visc Surg"},{"issue":"4","key":"2167_CR69","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.clinthera.2017.02.010","volume":"39","author":"F van Nooten","year":"2017","unstructured":"van Nooten\u00a0F, Treur\u00a0M, Pantiri\u00a0K, Stoker\u00a0M, Charokopou\u00a0M. Capsaicin 8\u202f% patch versus oral neuropathic pain medications for the treatment of painful diabetic peripheral neuropathy: a systematic literature review and network meta-analysis. Clin Ther. 2017;39(4):787\u2013803.e18.","journal-title":"Clin Ther"},{"key":"2167_CR70","unstructured":"Fachinformation-Qutenza. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/qutenza-epar-product-information_de.pdf. Zugegriffen: Internet."},{"key":"2167_CR71","first-page":"CD011976","volume":"9","author":"W Gibson","year":"2017","unstructured":"Gibson\u00a0W, Wand\u00a0BM, O\u2019Connell\u00a0NE. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database Syst Rev. 2017;9:CD11976.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2167_CR72","first-page":"83","volume":"115","author":"C Sommer","year":"2018","unstructured":"Sommer\u00a0C, Geber\u00a0C, Young\u00a0P, Forst\u00a0R, Birklein\u00a0F, Schoser\u00a0B. Polyneuropathies. Dtsch Arztebl Int. 2018;115(6):83\u201390.","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"2167_CR73","doi-asserted-by":"publisher","first-page":"e200681","DOI":"10.1001\/jamanetworkopen.2020.0681","volume":"3","author":"T Bao","year":"2020","unstructured":"Bao\u00a0T, Patil\u00a0S, Chen\u00a0C, Zhi\u00a0IW, Li\u00a0QS, Piulson\u00a0L, et al. Effect of acupuncture vs sham procedure on chemotherapy-induced peripheral neuropathy symptoms: a randomized clinical trial. JAMA Netw Open. 2020;3(3):e200681.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"2167_CR74","doi-asserted-by":"publisher","first-page":"e73764","DOI":"10.1371\/journal.pone.0073764","volume":"8","author":"W Chen","year":"2013","unstructured":"Chen\u00a0W, Yang\u00a0GY, Liu\u00a0B, Manheimer\u00a0E, Liu\u00a0JP. Manual acupuncture for treatment of diabetic peripheral neuropathy: a\u00a0systematic review of randomized controlled trials. PLoS One. 2013;8(9):e73764.","journal-title":"PLoS One"},{"key":"2167_CR75","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2147\/JPR.S37589","volume":"7","author":"T Wolter","year":"2014","unstructured":"Wolter\u00a0T. Spinal cord stimulation for neuropathic pain: current perspectives. J\u00a0Pain Res. 2014;7:651\u201363.","journal-title":"J Pain Res"},{"issue":"5","key":"2167_CR76","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1177\/193229681300700510","volume":"7","author":"G Thakral","year":"2013","unstructured":"Thakral\u00a0G, Kim\u00a0PJ, LaFontaine\u00a0J, Menzies\u00a0R, Najafi\u00a0B, Lavery\u00a0LA. Electrical stimulation as an adjunctive treatment of painful and sensory diabetic neuropathy. J\u00a0Diabetes Sci Technol. 2013;7(5):1202\u20139.","journal-title":"J Diabetes Sci Technol"},{"key":"2167_CR77","doi-asserted-by":"publisher","first-page":"5607898","DOI":"10.1155\/2021\/5607898","volume":"2021","author":"L Sun","year":"2021","unstructured":"Sun\u00a0L, Peng\u00a0C, Joosten\u00a0E, Cheung\u00a0CW, Tan\u00a0F, Jiang\u00a0W, et\u00a0al. Spinal cord stimulation and treatment of peripheral or central Neuropathic pain: Mechanisms and clinical application. Neural Plast. 2021;2021:5607898.","journal-title":"Neural Plast"},{"issue":"2","key":"2167_CR78","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/ner.13047","volume":"23","author":"KB Chapman","year":"2020","unstructured":"Chapman\u00a0KB, Groenen\u00a0PS, Patel\u00a0KV, Vissers\u00a0KC, van Helmond\u00a0N. T12 dorsal root ganglion stimulation to treat chronic low back pain: a case series. Neuromodulation. 2020;23(2):203\u201312.","journal-title":"Neuromodulation"},{"issue":"2","key":"2167_CR79","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.pmr.2022.02.005","volume":"33","author":"ST Potter","year":"2022","unstructured":"Potter\u00a0ST, Welch\u00a0S, Tata\u00a0F, Probert\u00a0S, Nagpal\u00a0A. Dorsal root ganglion stimulation. Phys Med Rehabil Clin N Am. 2022;33(2):359\u201378.","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"2167_CR80","volume-title":"Nationale VersorgungsrichtLeitlinie (NVL) Neuropahie bei Diabetes im Erwachsenenalter \u2013 Kurzfassung","author":"AWMF","year":"2012","unstructured":"AWMF. Nationale VersorgungsrichtLeitlinie (NVL) Neuropahie bei Diabetes im Erwachsenenalter \u2013 Kurzfassung. 1.\u00a0Aufl. 2012. Version 3, AWMF-Register-Nr.: nvl-001e.","edition":"1"},{"issue":"1","key":"2167_CR81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/1056-8727(92)90049-Q","volume":"6","author":"D Ziegler","year":"1992","unstructured":"Ziegler\u00a0D, Gries\u00a0FA, Sp\u00fcler\u00a0M, Lessmann\u00a0F. The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J\u00a0Diabetes Complications. 1992;6(1):49\u201357.","journal-title":"J Diabetes Complications"},{"issue":"24","key":"2167_CR82","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"ADVANCE Collaborative Group, Patel\u00a0A, MacMahon\u00a0S, Chalmers\u00a0J, Neal\u00a0B, Billot\u00a0L, et\u00a0al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N\u00a0Engl J Med. 2008;358(24):2560\u201372.","journal-title":"N Engl J Med"},{"issue":"2","key":"2167_CR83","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/jama.293.2.217","volume":"293","author":"N Singh","year":"2005","unstructured":"Singh\u00a0N, Armstrong\u00a0DG, Lipsky\u00a0BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217\u201328.","journal-title":"JAMA"},{"issue":"9","key":"2167_CR84","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans\u00a0V, Ricco\u00a0JB, Bartelink\u00a0MLEL, Bj\u00f6rck\u00a0M, Brodmann\u00a0M, Cohnert\u00a0T, et\u00a0al. 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart\u00a0J. 2018;39(9):763\u2013816.","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"2167_CR85","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/dmrr.2252","volume":"28","author":"NC Schaper","year":"2012","unstructured":"Schaper\u00a0NC, Andros\u00a0G, Apelqvist\u00a0J, Bakker\u00a0K, Lammer\u00a0J, Lepantalo\u00a0M, et\u00a0al. Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a\u00a0patient with diabetes and ulceration of the foot 2011. Diabetes Metab Res Rev. 2012;28(Suppl 1):236\u20137.","journal-title":"Diabetes Metab Res Rev"},{"key":"2167_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3266","author":"NC Schaper","year":"2020","unstructured":"Schaper\u00a0NC, Netten\u00a0JJ, Apelqvist\u00a0J, Bus\u00a0SA, Hinchliffe\u00a0RJ, Lipsky\u00a0BA, et\u00a0al. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020; https:\/\/doi.org\/10.1002\/dmrr.3266.","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"2167_CR87","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2337\/dc07-2367","volume":"31","author":"P Ince","year":"2008","unstructured":"Ince\u00a0P, Abbas\u00a0ZG, Lutale\u00a0JK, Basit\u00a0A, Ali\u00a0SM, Chohan\u00a0F, et\u00a0al. Use of the SINBAD classification system and score in comparing outcome of foot ulcer management on three continents. Diabetes Care. 2008;31(5):964\u20137.","journal-title":"Diabetes Care"},{"issue":"7","key":"2167_CR88","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-0034-1366455","volume":"122","author":"S Morbach","year":"2014","unstructured":"Morbach\u00a0S, M\u00fcller\u00a0E, Reike\u00a0H, Risse\u00a0A, R\u00fcmenapf\u00a0G, Spraul\u00a0M, et\u00a0al. Diabetic foot syndrome. Exp Clin Endocrinol Diabetes. 2014;122(7):416\u201324.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"2167_CR89","doi-asserted-by":"publisher","first-page":"39","DOI":"10.17219\/acem\/37020","volume":"23","author":"R Ma\u0142ecki","year":"2014","unstructured":"Ma\u0142ecki\u00a0R, Rosi\u0144ski\u00a0K, Adamiec\u00a0R. Etiological factors of infections in diabetic foot syndrome\u2014Attempt to define optimal empirical therapy. Adv Clin Exp Med. 2014;23(1):39\u201348.","journal-title":"Adv Clin Exp Med"},{"issue":"Suppl 1","key":"2167_CR90","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/dmrr.2246","volume":"28","author":"FL Game","year":"2012","unstructured":"Game\u00a0FL, Hinchliffe\u00a0RJ, Apelqvist\u00a0J, Armstrong\u00a0DG, Bakker\u00a0K, Hartemann\u00a0A, et\u00a0al. A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2012;28(Suppl 1):119\u201341.","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl 1","key":"2167_CR91","doi-asserted-by":"crossref","first-page":"e3283","DOI":"10.1002\/dmrr.3283","volume":"36","author":"G Rayman","year":"2020","unstructured":"Rayman\u00a0G, Vas\u00a0P, Dhatariya\u00a0K, Driver\u00a0V, Hartemann\u00a0A, Londahl\u00a0M, et\u00a0al. Guidelines on use of interventions to enhance healing of chronic foot ulcers in diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3283.","journal-title":"Diabetes Metab Res Rev"},{"key":"2167_CR92","first-page":"CD011038","volume":"6","author":"JC Dumville","year":"2017","unstructured":"Dumville\u00a0JC, Lipsky\u00a0BA, Hoey\u00a0C, Cruciani\u00a0M, Fiscon\u00a0M, Xia\u00a0J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev. 2017;6:CD11038.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2167_CR93","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S2213-8587(17)30438-2","volume":"6","author":"M Edmonds","year":"2018","unstructured":"Edmonds\u00a0M, L\u00e1zaro-Mart\u00ednez\u00a0JL, Alfayate-Garc\u00eda\u00a0JM, Martini\u00a0J, Petit\u00a0JM, Rayman\u00a0G, et al. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018;6(3):186\u201396.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2167_CR94","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/wrr.12434","volume":"24","author":"TBK Santema","year":"2016","unstructured":"Santema\u00a0TBK, Poyck\u00a0PPC, Ubbink\u00a0DT. Systematic review and meta-analysis of skin substitutes in the treatment of diabetic foot ulcers: Highlights of a\u00a0Cochrane systematic review. Wound Repair Regen. 2016;24(4):737\u201344.","journal-title":"Wound Repair Regen"},{"key":"2167_CR95","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.avsg.2018.10.013","volume":"56","author":"LH Hitchman","year":"2019","unstructured":"Hitchman\u00a0LH, Totty\u00a0JP, Raza\u00a0A, Cai\u00a0P, Smith\u00a0GE, Carradice\u00a0D, et al. Extracorporeal shockwave therapy for diabetic foot ulcers: a systematic review and meta-analysis. Ann Vasc Surg. 2019;56:330\u20139.","journal-title":"Ann Vasc Surg"},{"issue":"2","key":"2167_CR96","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jcjd.2019.05.006","volume":"44","author":"Q Huang","year":"2020","unstructured":"Huang\u00a0Q, Yan\u00a0P, Xiong\u00a0H, Shuai\u00a0T, Liu\u00a0J, Zhu\u00a0L, et al. Extracorporeal shock wave therapy for treating foot ulcers in adults with type 1 and type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Can J Diabetes. 2020;44(2):196\u2013204.e3.","journal-title":"Can J Diabetes"},{"issue":"3","key":"2167_CR97","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cpm.2017.02.008","volume":"34","author":"DJ Short","year":"2017","unstructured":"Short\u00a0DJ, Zgonis\u00a0T. Management of osteomyelitis and bone loss in the diabetic charcot foot and ankle. Clin Podiatr Med Surg. 2017;34(3):381\u20137.","journal-title":"Clin Podiatr Med Surg"},{"key":"2167_CR98","first-page":"439","volume-title":"Levin and O\u2019Neals\u2019s the diabetic foot","author":"L Sanders","year":"2001","unstructured":"Sanders\u00a0L, Frykberg\u00a0R. Charcot neuroarthropathy of the foot. In: Levin and O\u2019Neals\u2019s the diabetic foot. 2001. S.\u00a0439\u201366."}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-023-02167-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T14:54:52Z","timestamp":1702306492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-023-02167-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":98,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2167"],"URL":"https:\/\/doi.org\/10.1007\/s00508-023-02167-7","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"22 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.\u00a0K\u00f6hler hat von folgenden Unternehmen, die auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Honorare f\u00fcr Vortr\u00e4ge und Advisory Boards erhalten: Boehringer Ingelheim, Novo Nordisk, Amgen, Eli Lilly, Astra Zeneca, Viatris. M.\u00a0Eichner, H.\u00a0Abrahamian, M.\u00a0Kofler, W.\u00a0Sturm und A.\u00a0Menzel geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}